The U.S. Food and Drug Administration has downgraded the classification of full-field digital mammography devices from high risk to medium risk, making it easier for companies to bring the technology to market, the agency announced today.
FDA eases rules on digital mammography devices
Nov 3, 2010
Latest in Breast
CEM is a reliable tool for evaluating screening recalls
January 5, 2026















